Gaorong Ventures — Funding Activity & Portfolio Companies

Activity in this selectionOct 28, 2026 · Jan 1, 2026

Gaorong Ventures, also identified as Gaorong Capital, is the investment organization connected to Axoft and Moonwalk financing histories.

Recorded funding activity

Moonwalk develops medicines targeting fat-tissue pathways, while Axoft develops implanted brain-computer interfaces. The recorded activity also includes Anew’s combination of molecular models and experimental biology for drug discovery. These companies pursue different clinical technologies.

Sources

Rounds participated in: 7
Confirmed lead rounds: 0
New companies: 6
Funding in participating rounds: $1.4B

By stage

Undisclosed3

Series A2

Series B2

By primary sector

Biotech3

Healthtech2

AI1

Robotics1

By country

China4

United States2

Cayman Islands1

Rounds

7 in this selection

Sep 16

Anew Labs

An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.

$290MFunding

Participant

Sep 8

Moonwalk Biosciences

Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027.

$70MSeries B

Participant

Aug 24

Dogotix Inc. (XPeng Robotics)

Dogotix Inc. is the holding company for XPeng’s robotics business, which develops humanoid and other general-purpose robotic systems.

$900MConditional Series A subscription agreements

Participant

Jun 18

Evoken

Evoken builds AI tools for image, design and video production.

~$300MSeries B+

Participant